162 related articles for article (PubMed ID: 22863365)
1. Heat shock protein-inducing compounds as therapeutics to restore proteostasis in atrial fibrillation.
Hoogstra-Berends F; Meijering RA; Zhang D; Heeres A; Loen L; Seerden JP; Kuipers I; Kampinga HH; Henning RH; Brundel BJ
Trends Cardiovasc Med; 2012 Apr; 22(3):62-8. PubMed ID: 22863365
[TBL] [Abstract][Full Text] [Related]
2. Loss of proteostatic control as a substrate for atrial fibrillation: a novel target for upstream therapy by heat shock proteins.
Meijering RA; Zhang D; Hoogstra-Berends F; Henning RH; Brundel BJ
Front Physiol; 2012; 3():36. PubMed ID: 22375124
[TBL] [Abstract][Full Text] [Related]
3. Heat shock proteins as molecular targets for intervention in atrial fibrillation.
Brundel BJ; Ke L; Dijkhuis AJ; Qi X; Shiroshita-Takeshita A; Nattel S; Henning RH; Kampinga HH
Cardiovasc Res; 2008 Jun; 78(3):422-8. PubMed ID: 18326558
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective Role of Heat Shock Proteins in Atrial Fibrillation: From Mechanism of Action to Therapeutic and Diagnostic Target.
van Wijk SW; Ramos KS; Brundel BJJM
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466228
[TBL] [Abstract][Full Text] [Related]
5. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation.
Brundel BJ; Henning RH; Ke L; van Gelder IC; Crijns HJ; Kampinga HH
J Mol Cell Cardiol; 2006 Sep; 41(3):555-62. PubMed ID: 16876820
[TBL] [Abstract][Full Text] [Related]
7. The protective role of small heat shock proteins in cardiac diseases: key role in atrial fibrillation.
Hu X; Van Marion DMS; Wiersma M; Zhang D; Brundel BJJM
Cell Stress Chaperones; 2017 Jul; 22(4):665-674. PubMed ID: 28484965
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein inducer GGA*-59 reverses contractile and structural remodeling via restoration of the microtubule network in experimental Atrial Fibrillation.
Hu X; Li J; van Marion DMS; Zhang D; Brundel BJJM
J Mol Cell Cardiol; 2019 Sep; 134():86-97. PubMed ID: 31302117
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic Reticulum Stress Is Associated With Autophagy and Cardiomyocyte Remodeling in Experimental and Human Atrial Fibrillation.
Wiersma M; Meijering RAM; Qi XY; Zhang D; Liu T; Hoogstra-Berends F; Sibon OCM; Henning RH; Nattel S; Brundel BJJM
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066441
[TBL] [Abstract][Full Text] [Related]
10. Induction of heat shock response protects the heart against atrial fibrillation.
Brundel BJ; Shiroshita-Takeshita A; Qi X; Yeh YH; Chartier D; van Gelder IC; Henning RH; Kampinga HH; Nattel S
Circ Res; 2006 Dec; 99(12):1394-402. PubMed ID: 17110598
[TBL] [Abstract][Full Text] [Related]
11. Role of Heat Shock Proteins in Atrial Fibrillation: From Molecular Mechanisms to Diagnostic and Therapeutic Opportunities.
Liu D; Han X; Zhang Z; Tse G; Shao Q; Liu T
Cells; 2022 Dec; 12(1):. PubMed ID: 36611952
[TBL] [Abstract][Full Text] [Related]
12. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
[TBL] [Abstract][Full Text] [Related]
13. Screening of novel HSP-inducing compounds to conserve cardiomyocyte function in experimental atrial fibrillation.
van Marion DM; Hu X; Zhang D; Hoogstra-Berends F; Seerden JG; Loen L; Heeres A; Steen H; Henning RH; Brundel BJ
Drug Des Devel Ther; 2019; 13():345-364. PubMed ID: 30705583
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm.
Cohen M; Naccarelli GV
J Cardiovasc Electrophysiol; 2008 Aug; 19(8):885-90. PubMed ID: 18373600
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology and therapy of atrial fibrillation].
Capucci A; Aschieri D; Villani GQ
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
[TBL] [Abstract][Full Text] [Related]
16. Effects of different small HSPB members on contractile dysfunction and structural changes in a Drosophila melanogaster model for Atrial Fibrillation.
Zhang D; Ke L; Mackovicova K; Van Der Want JJ; Sibon OC; Tanguay RM; Morrow G; Henning RH; Kampinga HH; Brundel BJ
J Mol Cell Cardiol; 2011 Sep; 51(3):381-9. PubMed ID: 21745477
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
Burstein B; Nattel S
J Am Coll Cardiol; 2008 Feb; 51(8):802-9. PubMed ID: 18294563
[TBL] [Abstract][Full Text] [Related]
18. Management of atrial fibrillation.
Hersi A; Wyse DG
Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
[TBL] [Abstract][Full Text] [Related]
19. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
De Vos CB; Breithardt G; Camm AJ; Dorian P; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Crijns HJ
Am Heart J; 2012 May; 163(5):887-93. PubMed ID: 22607868
[TBL] [Abstract][Full Text] [Related]
20. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease.
Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Sparks PB; Morton JB; Kalman JM
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):232-8. PubMed ID: 21955090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
